Scotch Plains, NJ, United States of America

Raymond Cvetovich

This inventor holds 19 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 2 EPO patents. Top assignees: Merck + Co., Inc., Paratek Pharmaceuticals, Inc.. Active years: 1991-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Raymond Cvetovich. Retrieved from https://idiyas.com/inventor/raymond-cvetovich

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 3)

% Patents Active = 94.7

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 2.1

ph-index = 5

Forward Citations = 92(Granted Patents)

Location History:

Jersey City, NJ (US) (2013)
Scotch Plains, NJ (US) (1991 - 2016)

Company Filing History:

Paratek Pharmaceuticals, Inc.

patents

Years Active: 1991-2016

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9227921 - Salts and polymorphs of a tetracycline compound (2016-01-05),

2. 8383610 - Salts and polymorphs of 9-(2,2-dimethylpropyl-aminomethyl) minocycline (2013-02-26),

3. RE40794 - Crystalline forms of carbapenem antibiotics and methods of preparation (2009-06-22),

4. 7145002 - Crystalline forms of carbapenem antibiotics and methods of preparation (2006-12-05),

5. 7022841 - Process for making carbapenem compounds (2006-04-04),

6. 6814895 - Process for the synthesis of 1-(3,5-bis(trifluoromethyl)phenyl)ethan-1-one (2004-11-09),

7. 6489507 - Process for the synthesis of 3,5-bis(trifluoromethyl)benzoic acid (2002-12-03),

8. 6486195 - Thermodynamically stable crystal form of 4″-deoxy-4″-epi-methylamino avermectin B1a/B1b benzoic acid salt and processes for its preparation (2002-11-26),

9. 6350915 - Process for the synthesis of 1-(3,5-bis(trifluoromethyl)-phenyl)ethan-1-one (2002-02-26),

10. 6255545 - Process for the synthesis of 3,5-bis(trifluoromethyl)-bromobenzene (2001-07-03),

11. 5808056 - Process for preparing substituted azetidinones (1998-09-15),

12. 5523233 - Enzymatic hydrolysis of 3,3-diethyl-4-[(4-carboxy)phenoxy]-2-azetidinone (1996-06-04),

13. 5420260 - Process for 4'-epi-acetylamino-4'-deoxy-5-oximinoavermectin B.sub.1 (1995-05-30),

14. 5399717 - Glycosidation route to 4'-epi-methylamino-4'-deoxyavermectin B.sub.1 (1995-03-21),

15. 5380838 - Stable solvates of avermectin compounds (1995-01-10),

Title: Innovations of Raymond Cvetovich: A Pioneer in Tetracycline Compounds

Introduction: Raymond Cvetovich, based in Scotch Plains, NJ, is a renowned inventor with a significant contribution to pharmaceutical innovations, particularly in the field of tetracycline compounds. With a portfolio of 19 patents, Cvetovich's work has advanced the treatment of various bacterial infections and related disorders.

Latest Patents: Among his most recent innovations are two notable patents that focus on crystalline forms of tetracycline compounds. The first patent provides salts and polymorphs of a tetracycline compound, offering crystalline compounds that are instrumental in treating conditions responsive to tetracycline. These crystalline forms are particularly relevant for addressing bacterial infections and neoplasms, showcasing their broad therapeutic potential. The second patent details salts and polymorphs of 9-(2,2-dimethylpropyl-aminomethyl) minocycline, emphasizing similar applications in treating tetracycline-responsive states, further affirming Cvetovich's pivotal role in this healthcare niche.

Career Highlights: Cvetovich has made significant strides during his career, contributing to leading pharmaceutical companies such as Merck & Company, Inc. and Paratek Pharmaceuticals, Inc. His research and development efforts have paved the way for advancements in antibiotic treatments, underlining his commitment to innovation in the pharmaceutical industry.

Collaborations: In his journey, Cvetovich has collaborated with esteemed professionals like Joseph S Amato and Louis S Crocker. These partnerships have facilitated the exchange of ideas and expertise, enriching his research and enhancing the impact of his inventions.

Conclusion: Raymond Cvetovich's contributions to the field of tetracycline compounds reflect his dedication to improving medical treatments through innovation. His extensive patent portfolio and impactful collaborations have established him as a prominent figure in pharmaceutical research, paving the way for future advancements in the treatment of bacterial infections and related disorders.

Profile summary based on public USPTO records.